HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Inagaki Selected Research

Cholangiocarcinoma

8/2009Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Inagaki Research Topics

Disease

8Neoplasms (Cancer)
07/2015 - 03/2003
8Diabetic Retinopathy (Retinopathy, Diabetic)
04/2003 - 01/2002
5Periodontitis
06/2018 - 10/2012
3Diabetes Mellitus
07/2015 - 06/2001
3Hepatocellular Carcinoma (Hepatoma)
02/2013 - 08/2009
3Diabetic Angiopathies (Diabetic Angiopathy)
01/2003 - 01/2002
2Periodontal Diseases (Periodontal Disease)
06/2018 - 03/2017
2Inflammation (Inflammations)
06/2016 - 04/2015
2Carcinoma (Carcinomatosis)
01/2011 - 08/2009
2Neoplasm Metastasis (Metastasis)
10/2008 - 03/2003
2Atherosclerosis
01/2003 - 01/2003
1Polyuria
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
07/2015
1Infections
05/2015
1Diabetes Complications
04/2015
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2013
1Multiple Sclerosis
01/2013
1Insulin Resistance
10/2012
1Breast Neoplasms (Breast Cancer)
01/2011
1Colonic Neoplasms (Colon Cancer)
01/2011
1Bacterial Infections (Bacterial Infection)
02/2010
1Chronic Periodontitis
12/2009
1Cholangiocarcinoma
08/2009
1Stomach Neoplasms (Stomach Cancer)
02/2009
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2008
1Alzheimer Disease (Alzheimer's Disease)
01/2004
1Eye Diseases (Eye Disease)
01/2002
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2002
1Atrophy
01/2002
1Body Weight (Weight, Body)
01/2002

Drug/Important Bio-Agent (IBA)

5Retinaldehyde (Retinal)IBA
01/2003 - 06/2001
4Advanced Glycation End ProductsIBA
06/2018 - 01/2002
3Angiotensin IIIBA
01/2022 - 01/2003
3LipopolysaccharidesIBA
03/2017 - 10/2012
3pigment epithelium-derived factorIBA
01/2004 - 01/2002
2Collagen Type I (Type I Collagen)IBA
06/2016 - 01/2011
2Proteins (Proteins, Gene)FDA Link
07/2015 - 02/2009
2Mucin-1 (CA 15-3 Antigen)IBA
08/2009 - 10/2008
2MucinsIBA
08/2009 - 10/2008
2DNA (Deoxyribonucleic Acid)IBA
03/2003 - 03/2000
2Nifedipine (Adalat)FDA LinkGeneric
01/2003 - 01/2003
2Propofol (Diprivan)FDA LinkGeneric
11/2001 - 06/2000
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022
1arginine methyl esterIBA
01/2022
1SaltsIBA
01/2022
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2022
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2018
1Interleukin-6 (Interleukin 6)IBA
06/2018
1Therapeutic UsesIBA
03/2017
1eIF-2 Kinase (eIF 2 Kinase)IBA
03/2017
1Double-Stranded RNA (RNA, Double Stranded)IBA
03/2017
1Messenger RNA (mRNA)IBA
06/2016
1OsteocalcinIBA
06/2016
1ChitinIBA
07/2015
1Glycoproteins (Glycoprotein)IBA
07/2015
1chloroacetate esteraseIBA
05/2015
1InterleukinsIBA
04/2015
1FlavonoidsIBA
02/2013
1ceralifimodIBA
01/2013
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2013
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
10/2012
1CytokinesIBA
10/2012
1ResistinIBA
10/2012
1AdipokinesIBA
10/2012
1Pharmaceutical PreparationsIBA
02/2011
1Sorafenib (BAY 43-9006)FDA Link
02/2011
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2011
1CollagenIBA
01/2011
1GelsIBA
01/2011
1Antimicrobial PeptidesIBA
02/2010
1Calcitriol Receptors (Calcitriol Receptor)IBA
12/2009
1Biomarkers (Surrogate Marker)IBA
01/2004
1polyolIBA
04/2003
1Genetic Markers (Genetic Marker)IBA
04/2003
1L-Iditol 2-Dehydrogenase (L Iditol 2 Dehydrogenase)IBA
04/2003
1Angiogenesis InhibitorsIBA
03/2003
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2003
1Chemotactic FactorsIBA
01/2003
11,4-dihydropyridine (dihydropyridine)IBA
01/2003
1Becaplermin (PDGF-BB)FDA Link
01/2003
1CalciumIBA
01/2003
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2003
1MitogensIBA
01/2003
1HaptoglobinsIBA
07/2002
1GlyceraldehydeIBA
01/2002
1Glucose (Dextrose)FDA LinkGeneric
01/2002
1LeptinIBA
01/2002
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2002
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2002
1Collagen Type IV (Type IV Collagen)IBA
01/2002
1Hormones (Hormone)IBA
01/2002
1DilazepIBA
01/2002
1Insulin (Novolin)FDA Link
01/2002

Therapy/Procedure

3Therapeutics
02/2013 - 06/2001
1Glycemic Control
06/2018
1Ligation
03/2017
1Knee Replacement Arthroplasty (Total Knee Replacement)
05/2015
1Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2013
1Drug Therapy (Chemotherapy)
02/2013